Planta Med 2003; 69(6): 566-568
DOI: 10.1055/s-2003-40642
Letter
© Georg Thieme Verlag Stuttgart · New York

Estrogenic Activity of Phenylpropanoids from Sarcomelicope megistophylla and Structure Determination of a New Norneolignan

Nikolas Fokialakis1 , Prokopios Magiatis1 , Sofia Mitaku1 , Harris Pratsinis2 , François Tillequin3
  • 1Department of Pharmacy, Laboratory of Pharmacognosy, University of Athens, Athens, Greece
  • 2Laboratory of Cell Proliferation & Ageing, Institute of Biology, NCSR ”Demokritos”, Athens, Greece
  • 3Laboratoire de Pharmacognosie de l’Université René Descartes, UMR/CNRS No 8638, Faculté de Pharmacie, Paris, France
Further Information

Publication History

Received: October 14, 2002

Accepted: February 15, 2003

Publication Date:
16 July 2003 (online)

Preview

Abstract

Bioassay-guided fractionation of the neutral extract of the bark of Sarcomelicope megistophylla resulted in the isolation of the new nor-neolignan sarcomeginal (1), together with the known ailanthoidol (2) and (±)-seco-isolariciresinol (3). The structure of 1 was determined by spectroscopic means. Estrogenic activity of the isolated compounds was tested using estrogen receptor-positive MCF7 and estrogen receptor-negative MDA-MB-231 human mammary adenocarcinoma cell lines. Compound 3 displayed significant estrogenic activity.

References

Sofia Mitaku

Department of Pharmacy

Laboratory of Pharmacognosy

University of Athens

Panepistimiopolis Zografou

15771 Athens

Greece

Fax: +32-10-7274594

Email: mitakou@pharm.uoa.gr